Articles

Information about the TGA's safety monitoring of COVID-19 vaccines.

Medicines Safety Update - Information for health professionals

Medicines Safety Update - Information for health professionals

The TGA is providing guidance on surrogate viruses that may be used to test disinfectants making claims of efficacy against Monkeypox.

COVID-19 vaccines that have received a provisional determination from the TGA.

On 5 July 2022 the TGA granted two provisional determinations to Pfizer Australia Pty Ltd.

Direction Notice issued to cease advertisement of prescription and illegal products

Precision Pharmaceuticals Pty Ltd fined and directed to cease alleged unlawful advertising of nicotine vaping products

Information about the TGA's safety monitoring of COVID-19 vaccines.

On 28 June 2022 the TGA granted a provisional determination to Pfizer Australia Pty Ltd in relation to its COVID-19 Vaccine, COMIRNATY.

Information about the TGA's safety monitoring of COVID-19 vaccines.

The TGA has issued eight (8) infringement notices totalling $106,560 to Hough Pharma Pty Ltd for allegedly failing to provide information to the TGA to demonstrate the safety and performance of three COVID-19 RATs.

Medicines Safety Update - Information for health professionals

This Order revokes Therapeutic Goods (Groups) Order No. 1 of 1992.

This Order may be cited as Therapeutic Goods (Groups) Order No. 1 of 1992.

This Order revokes Therapeutic Goods (Groups) Order No. 1 of 1991.

Information about the TGA's safety monitoring of COVID-19 vaccines.

The TGA has commenced court proceedings in the Federal Court of Australia against Prefixx Pty Ltd and its sole director for alleged unlawful advertising of nicotine vaping products.

When new safety information for medicines is identified, the Therapeutic Goods Administration (TGA) works with the sponsors to update Product Information (PI) to ensure that health professionals and consumers have access to this information.

Information about the TGA's safety monitoring of COVID-19 vaccines.

The transition period from the 2018 to the 2021 Advertising Code ends 30 June 2022.

The TGA has issued one infringement notice totalling $2,664 to a Queensland based individual for alleged unlawful advertising of therapeutic goods in relation to COVID-19.

The TGA has issued four infringement notices totalling $10,664 to an individual for alleged unlawful importation of COVID-19 rapid antigen tests (RATs).

The TGA has issued one infringement notice of $2,664 to a NSW based individual for the alleged unlawful advertising of a medicine that was not included in the Australian Register of Therapeutic Goods.

The TGA has issued ten infringement notices totalling $133,200 to Philips Electronics Australia Ltd.